News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mathers Thomas P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/20/2020 |
3
| Mathers Thomas P. (Director) has filed a Form 3 on Lifesci Acquisition II Corp. |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 802 shares
@ $34.2462, valued at
$27.5k
Sold 200 shares
@ $34.8625, valued at
$7k
Sold 500 shares
@ $35.6, valued at
$17.8k
Exercised 3,755 restricted stock units
@ $0 |
|
| 12/05/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,502 shares
@ $38.75, valued at
$58.2k
Exercised 3,756 restricted stock units
@ $0 |
|
| 11/07/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,502 shares
@ $28.5732, valued at
$42.9k
Exercised 3,755 restricted stock units
@ $0 |
|
| 10/05/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,502 shares
@ $37.08, valued at
$55.7k
Exercised 3,755 restricted stock units
@ $0 |
|
| 09/16/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 5,700 shares
@ $23.3004, valued at
$132.8k
Sold 300 shares
@ $23.78, valued at
$7.1k
|
|
| 09/07/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,502 shares
@ $19.5, valued at
$29.3k
Sold 663 shares
@ $20.5555, valued at
$13.6k
Sold 962 shares
@ $21.9045, valued at
$21.1k
Sold 2,633 shares
@ $22.6164, valued at
$59.5k
Sold 442 shares
@ $23.4267, valued at
$10.4k
Sold 300 shares
@ $24.3967, valued at
$7.3k
Exercised 3,756 restricted stock units
@ $0 |
|
| 08/05/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,502 shares
@ $8.31, valued at
$12.5k
Exercised 3,755 restricted stock units
@ $0 |
|
| 07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,502 shares
@ $7.2463, valued at
$10.9k
Exercised 3,756 restricted stock units
@ $0 |
|
| 05/09/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 14,624 shares
@ $6.49, valued at
$94.9k
Exercised 45,064 restricted stock units
@ $0 |
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|